You have free access to this content

Value in Health

Cover image for Value in Health

July 2003

Volume 6, Issue 4

Pages 403–499

  1. Editorials

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      Decision Makers’ Needs as Capacities to Benefit (page 403)

      Jack Dowie

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64001.x

    2. You have free access to this content
      Do Decision Makers Really Need Health Economic Data? (pages 404–406)

      Dell Mather

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64002.x

  2. Ispor Scientific Task Force Report

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      Use of Pharmacoeconomics Information—Report of the ISPOR Task Force on Use of Pharmacoeconomic/Health Economic Information in Health-Care Decision Making (pages 407–416)

      Michael Drummond, Ruth Brown, A. Mark Fendrick, Pete Fullerton, Peter Neumann, Rod Taylor and Marco Barbieri

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64245.x

  3. Commentaries

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      Cost-Effectiveness Analysis in Health Policy (pages 417–419)

      John D. Graham

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64003.x

    2. You have free access to this content
      Risk Management: Issues for Outcomes Research (pages 420–424)

      Janet Woodcock

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64004.x

  4. Policy and Application

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      Cost-Effectiveness Analysis of Pharmaceutical Care in a Medicare Drug Benefit Program (pages 425–435)

      Lida R. Etemad and Joel W. Hay

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64255.x

  5. Commentary

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      Cost-Effectiveness of Migraine Treatment: A Commentary (pages 436–437)

      Dean G. Smith

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64005.x

  6. Empirical Research

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
      A Cost-Effectiveness Analysis of Eletriptan 40 and 80 mg versus Sumatriptan 50 and 100 mg in the Acute Treatment of Migraine (pages 438–447)

      Nicholas Wells, Jayasena Hettiarachchi, Michael Drummond, MCom DPhil, David Carter, Tamiza Parpia and Francis Pang

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64238.x

    2. You have free access to this content
      Seasonal versus Perennial Allergic Rhinitis: Drug and Medical Resource Use Patterns (pages 448–456)

      William H. Crown, Abayomi Olufade, Mark W. Smith and Robert Nathan

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64231.x

    3. You have free access to this content
      Cost Implications of Administering Intravenous Proton Pump Inhibitors to All Patients Presenting to the Emergency Department with Peptic Ulcer Bleeding (pages 457–465)

      Yves M. Gagnon, Adrian R. Levy, Mohamad A. Eloubeidi, Miguel R. Arguedas, Kevin P. Rioux and Robert A. Enns

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64262.x

    4. You have free access to this content
      The Impact of Including Passive Benefits in Cost-Effectiveness Analysis: The Case of Automated External Defibrillators on Commercial Aircraft (pages 466–473)

      Peter Cram, Sandeep Vijan, Alex Wolbrink and A. Mark Fendrick

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64224.x

  7. Methodologies

    1. Top of page
    2. Editorials
    3. Ispor Scientific Task Force Report
    4. Commentaries
    5. Policy and Application
    6. Commentary
    7. Empirical Research
    8. Methodologies
    1. You have free access to this content
    2. You have free access to this content
    3. You have free access to this content
      Future Burden and Costs of Smoking-Related Disease in the Netherlands: A Dynamic Modeling Approach (pages 494–499)

      Marianne L.L. Van Genugten, Rudolf T. Hoogenveen, Ina Mulder, Henriëtte A. Smit, Jan Jansen and Augustinus E.M. De Hollander

      Version of Record online: 10 JUL 2003 | DOI: 10.1046/j.1524-4733.2003.64157.x

SEARCH

SEARCH BY CITATION